NASDAQ:GENE

Delisted

Genetic Technologies Stock News

Healthcare > Medical - Diagnostics & Research

Buy GENE

*Your capital is at risk

$0.765

+0 (+0%)

At Close: Jan 15, 2025

Genetic Technologies Releases Non-Renounceable Rights Issue Document

12:00am, Friday, 11'th Oct 2019

Genetic Technologies to Issue Up to 1.13B Fully Paid Ordinary Shares @ A$0.004/New Ordinary Share

12:00am, Friday, 04'th Oct 2019

Genetic Technologies Says Continues to Explore Funding Alternatives

12:00am, Monday, 23'rd Sep 2019

Collaboration Agreement Signed Between Genetic Technologies and Translational Genomics Research Institute

12:00am, Sunday, 22'nd Sep 2019

60 Biggest Movers From Friday

12:00am, Monday, 26'th Aug 2019

42 Stocks Moving In Friday's Mid-Day Session

12:00am, Friday, 23'rd Aug 2019

25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

12:00am, Wednesday, 21'st Aug 2019

Stocks That Hit 52-Week Lows On Friday

12:00am, Friday, 16'th Aug 2019

46 Stocks Moving In Thursday's Mid-Day Session

12:00am, Thursday, 15'th Aug 2019

Genetic Technologies Announces Cancellation of Blockshine Health JV Agreement

12:00am, Tuesday, 06'th Aug 2019

Genetic Technologies Says Received Letter From Nasdaq That It Has Failed to Regain Compliance With $1.00 Minimum Bid Price of Its ADRs; Will Appeal Nasdaq Delisting Notice

12:00am, Tuesday, 30'th Jul 2019

Genetic Technologies Appoints Phillip Hains as CFO Replacing Paul Viney

12:00am, Thursday, 11'th Jul 2019

Genetic Technologies Stock News

Genetic Technologies Releases Non-Renounceable Rights Issue Document

Genetic Technologies to Issue Up to 1.13B Fully Paid Ordinary Shares @ A$0.004/New Ordinary Share

Genetic Technologies Says Continues to Explore Funding Alternatives

Collaboration Agreement Signed Between Genetic Technologies and Translational Genomics Research Institute

60 Biggest Movers From Friday

42 Stocks Moving In Friday's Mid-Day Session

25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Stocks That Hit 52-Week Lows On Friday

46 Stocks Moving In Thursday's Mid-Day Session

Genetic Technologies Announces Cancellation of Blockshine Health JV Agreement

Genetic Technologies Says Received Letter From Nasdaq That It Has Failed to Regain Compliance With $1.00 Minimum Bid Price of Its ADRs; Will Appeal Nasdaq Delisting Notice

Genetic Technologies Appoints Phillip Hains as CFO Replacing Paul Viney

Genetic Technologies Shares Tick Lower To Session Lows; Traders Circulate European Patent Specification For 'Methods for genomic analysis'

Genetic Technologies Reports Offering Of 1.2M ADSs

TME and SLDB among premarket losers

Top Fintech Company